Identification of the flavivirus conserved residues in the envelope protein hinge region for the rational design of a candidate West Nile live-attenuated vaccine
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of the flavivirus conserved residues in the envelope protein hinge region for the rational design of a candidate West Nile live-attenuated vaccine
Authors
Keywords
-
Journal
npj Vaccines
Volume 8, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-07
DOI
10.1038/s41541-023-00765-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Designed, highly expressing, thermostable dengue virus 2 envelope protein dimers elicit quaternary epitope antibodies
- (2021) Stephan T. Kudlacek et al. Science Advances
- The continued threat of emerging flaviviruses
- (2020) Theodore C. Pierson et al. Nature Microbiology
- The Hantavirus Surface Glycoprotein Lattice and Its Fusion Control Mechanism
- (2020) Alexandra Serris et al. CELL
- Twenty Years of Progress Toward West Nile Virus Vaccine Development
- (2019) Jaclyn A. Kaiser et al. Viruses-Basel
- Genotypic and phenotypic characterization of West Nile virus NS5 methyltransferase mutants
- (2019) Jaclyn A. Kaiser et al. VACCINE
- A review of Dengvaxia®: development to deployment
- (2019) Stephen J. Thomas et al. Human Vaccines & Immunotherapeutics
- An attenuated Zika virus NS4B protein mutant is a potent inducer of antiviral immune responses
- (2019) Guangyu Li et al. npj Vaccines
- Japanese encephalitis vaccine-specific envelope protein E138K mutation does not attenuate virulence of West Nile virus
- (2019) Jaclyn A. Kaiser et al. npj Vaccines
- Shedding of Japanese Encephalitis Virus in Oral Fluid of Infected Swine
- (2018) Amy C. Lyons et al. VECTOR-BORNE AND ZOONOTIC DISEASES
- Virulence determinants of West Nile virus: how can these be used for vaccine design?
- (2017) Jaclyn A Kaiser et al. Future Virology
- Near-atomic structure of Japanese encephalitis virus reveals critical determinants of virulence and stability
- (2017) Xiangxi Wang et al. Nature Communications
- A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis
- (2017) Leslie Goo et al. PLoS Pathogens
- Mechanistic Insight into Bunyavirus-Induced Membrane Fusion from Structure-Function Analyses of the Hantavirus Envelope Glycoprotein Gc
- (2016) Pablo Guardado-Calvo et al. PLoS Pathogens
- The efficacy of inactivated West Nile vaccine (WN-VAX) in mice and monkeys
- (2015) Yuko Muraki et al. Virology Journal
- Distance-dependent hydrophobic–hydrophobic contacts in protein folding simulations
- (2014) Angelo Onofrio et al. PHYSICAL CHEMISTRY CHEMICAL PHYSICS
- WHO working group on the quality, safety and efficacy of Japanese encephalitis vaccines (live attenuated) for human use, Bangkok, Thailand, 21–23 February 2012
- (2013) Dennis W. Trent et al. BIOLOGICALS
- A detailed comparative analysis on the overall codon usage patterns in West Nile virus
- (2013) Gonzalo Moratorio et al. INFECTION GENETICS AND EVOLUTION
- Atomic-level functional model of dengue virus Envelope protein infectivity
- (2013) E. A. Christian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rational Design of a Live Attenuated Dengue Vaccine: 2′-O-Methyltransferase Mutants Are Highly Attenuated and Immunogenic in Mice and Macaques
- (2013) Roland Züst et al. PLoS Pathogens
- Cryo-EM structure of the mature dengue virus at 3.5-Å resolution
- (2012) Xiaokang Zhang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness
- (2011) Melissa C. Whiteman et al. VACCINE
- Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion
- (2011) Siritorn Butrapet et al. VIROLOGY
- WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13–14 May 2009
- (2010) Morag Ferguson et al. VACCINE
- Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus
- (2009) Melissa C. Whiteman et al. VACCINE
- Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses
- (2009) Bruno Guy et al. VACCINE
- The dengue virus type 2 envelope protein fusion peptide is essential for membrane fusion
- (2009) Claire Y.-H. Huang et al. VIROLOGY
- Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses
- (2008) John T. Roehrig et al. VIRAL IMMUNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started